Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Atorvastatin reduces free radical production in VSMCs

May 11, 2001

New vitamin D3 derivatives and their use described by Chugai

May 10, 2001

Cysteine protease inhibitors undergo research at Kissei

May 10, 2001

Patented series from BMS particularly useful for type 2 diabetes

May 10, 2001

Biopure's Hemopure blood substitute proves highly effective in pivotal trial

May 10, 2001

TLK-16998: a nonpeptide IR sensitizer effective in mouse models of type 2 diabetes

May 9, 2001

Theratechnologies and Alza to develop ThGRF in a Macroflux system

May 8, 2001

PTP inhibitors emerge from Novo Nordisk/Ontogen collaboration

May 7, 2001

Hectorol approved by Canadian health authorities

May 7, 2001

Novo Nordisk licenses GH-stimulating compounds to Rejuvenon

May 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...